Ikena Oncology, Inc. (IKNA) stock declined over -5.19% intraday to trade at $4.20 a share on NASDAQ. The stock opened with a loss of -4.11% at $4.51 and touched an intraday high of $4.52, falling -5.19% against the last close of $4.43. The stock went to a low of $4.11 during the session.
Number of Shares
Cash Flow per Share
Free Float in %
Sales or Revenue30.98 Million
5Y Sales Change-
Fiscal Year Ends2021-12-30
Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. It is also developing a small molecule inhibitor program against ERK5 in the RAS signaling pathway; IK-175, an oral inhibitor of aryl hydrocarbon receptor; and IK-007, an oral selective EP4 receptor antagonist for the treatment of microsatellite stable colorectal cancer. The company was incorporated in 2016 and is headquartered in Boston, Massachusetts.
Ikena Oncology, Inc. (NASDAQ: IKNA) stock price is $4.2 as of the last check on Friday, July 1. During the trading session, IKNA stock reached the peak price of $4.52 while $4.11 was the lowest point it dropped to.
The NASDAQ listed IKNA is part of Pharmaceuticals industry that operates in the broader Health Care sector. Ikena Oncology, Inc. , a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs.
Mr. Francisco Oliveira
Head of Fin. & Admin. and Acting Principal Accounting Officer
Ms. Maude Tessier Ph.D.
Chief Bus. Officer
Dr. Mark Manfredi Ph.D.
Pres. CEO & Director
Dr. Sergio L. Santillana M.B.A., M.D., M.Sc., MSc
Chief Medical Officer
IKNA stock traded closed the last session at $4.2, which is $-0.23 or -5.19% lower than its previous close of $4.43. IKNA's current trading price is 48.41% lower than its 52-week high of $17.60 where as its distance from 52-week low of 2.83% is -76.14%.
Number of IKNA employees currently stands at -. IKNA operates from 645 Summer Street, Suite 101, Boston, MA 02210, United States.
Official Webiste of $IKNA is: https://ikenaoncology.com
IKNA stock volume for the day was 63,126 shares while in the previous session number of IKNA shares traded was 63,100 . The average number of IKNA shares traded daily for last 3 months was 292.13 Thousands.
The percentage change in IKNA stock occurred in the recent session was -5.19% while the dollar amount for the price change in IKNA stock was $-0.23.
In the recent session, the day high for IKNA stock was $4.52 while the low for IKNA stock touched on the day was $4.11.
The market value of IKNA currently stands at 160.19 Million with its latest stock price at $4.2 and 36.08 Million of its shares outstanding.